Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study

J Clin Oncol. 2009 Jul 1;27(19):e3-4. doi: 10.1200/JCO.2009.22.0863. Epub 2009 May 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Alkaline Phosphatase / blood
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capecitabine
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Epirubicin / administration & dosage
  • Esophageal Neoplasms / blood
  • Esophageal Neoplasms / mortality*
  • Esophageal Neoplasms / pathology*
  • Esophagogastric Junction / pathology
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Health Status Indicators*
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms / secondary
  • Multicenter Studies as Topic
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Peritoneal Neoplasms / secondary
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Stomach Neoplasms / blood
  • Stomach Neoplasms / mortality*
  • Stomach Neoplasms / pathology*

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Deoxycytidine
  • Epirubicin
  • Capecitabine
  • Alkaline Phosphatase
  • Fluorouracil